The Enterprise Value as of June 2026 (TTM) for Sonnet BioTherapeutics Holdings, Inc. (SONN) is 3.36M

According to Sonnet BioTherapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 3.36M. This represents a change of -32.02% compared to the average of 4.94M of the last 4 quarters.

Sonnet BioTherapeutics Holdings, Inc. (SONN) Historical Enterprise Value (quarterly & annually)

How has SONN Enterprise Value performed in the past?

The mean historical Enterprise Value of Sonnet BioTherapeutics Holdings, Inc. over the last ten years is 13.10M. The current 3.36M Enterprise Value has changed 2.46% with respect to the historical average. Over the past ten years (40 quarters), SONN's Enterprise Value was at its highest in in the June 2020 quarter at 79.19M. The Enterprise Value was at its lowest in in the September 2021 quarter at -13255022.57.

Sonnet BioTherapeutics Holdings, Inc. (SONN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sonnet BioTherapeutics Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sonnet BioTherapeutics Holdings, Inc. (SONN) Average Enterprise Value

How has SONN Enterprise Value performed in the past?

The current Enterprise Value of Sonnet BioTherapeutics Holdings, Inc. (SONN) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Sonnet BioTherapeutics Holdings, Inc. (SONN) Enterprise Value vs. Peers

How is SONN’s Enterprise Value compared to its peers?

Sonnet BioTherapeutics Holdings, Inc.’s Enterprise Value is less than Rallybio Corporation (43.20M), less than TAO Synergies Inc. (8.25M), less than Klotho Neurosciences, Inc. (13.75M), less than Exicure, Inc. (15.14M), greater than Intensity Therapeutics, Inc. (-3315836.00), less than Iterum Therapeutics plc (24.60M), less than Boundless Bio, Inc. (62.48M), less than Q32 Bio Inc. (121.73M), less than Cadrenal Therapeutics, Inc. Common Stock (8.30M), greater than iBio, Inc. (-18621791.00),

Build a custom stock screener for Sonnet BioTherapeutics Holdings, Inc. (SONN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sonnet BioTherapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sonnet BioTherapeutics Holdings, Inc. (SONN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sonnet BioTherapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.